The interplay between prostate cancer genomics, metabolism, and the epigenome: perspectives and future prospects
Prostate cancer is a high-incidence cancer, often detected late in life. The prostate gland is an accessory gland that secretes citrate; an impaired citrate secretion reflects imbalances in the activity of enzymes in the TCA Cycle in mitochondria. Profiling studies on prostate tumours have identifie...
Autors principals: | Singh, R, Mills, IG |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Frontiers Media
2021
|
Ítems similars
-
The Interplay Between Prostate Cancer Genomics, Metabolism, and the Epigenome: Perspectives and Future Prospects
per: Reema Singh, et al.
Publicat: (2021-09-01) -
Genomic and epigenomic alterations in prostate cancer
per: Anna Maria eAschelter, et al.
Publicat: (2012-11-01) -
Understanding the Interplay Between Health Disparities and Epigenomics
per: Viviana J. Mancilla, et al.
Publicat: (2020-08-01) -
The Interplay Between Diet and the Epigenome in the Pathogenesis of Type-1 Diabetes
per: Amira Kohil, et al.
Publicat: (2021-01-01) -
Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients
per: Claire Stevens, et al.
Publicat: (2023-02-01)